FDA DEVICE FACTS
The Optimotion Blue Total Knee System
Optimotion Implants, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
« Painful, disabling joint disease of the knee resulting from; noninflammatory degenerative joint disease (including osteoarthritis, traumatic arthritis, or avascular necrosis), rheumatoid arthritis or post-traumatic arthritis.
¢ Post-traumatic loss of knee joint configurations and function.
¢ Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability.
¢ Revision of previous unsuccessful knee replacement or other procedure.
¢ Fracture of the distal femur and/or proximal tibia that cannot be stabilized by standard fracture-management techniques.
Optimotion™ Blue Porous Tibial Baseplate components are indicated for Cemented or Cementless use. The Optimotion™ Blue Porous CR Femoral components are indicated for Cemented or Cementless use. The Optimotion™ Blue CEMENTED CR Femoral and CEMENTED Tibial Baseplate components are indicated for cemented use only.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。